Bakterial'nyy vaginoz: kak snizit' chislo retsidivov?


Cite item

Full Text

Abstract

References

  1. Европейское руководство по ведению больных с патологическими выделениями из влагалища совместно с ВОЗ, 2011.
  2. Hillier S, Marrazzo J, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Stamm VE, Piot P, Wasserheit JN, Corey L et al (eds). Sexually transmitted diseases, 4th edn. New York: McGraw-Hill, 2008; p. 737-68.
  3. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109: 114.
  4. Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 450.
  5. Ling Z, Kong J, Liu F et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 2010; 11: 488.
  6. Eschenbach DA, Davick PR, Williams BL et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1993; 27: 251.
  7. Lamont RF, Sobel JD, Akins RA et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011; 118: 533.
  8. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899.
  9. Fredricks DN, Fiedler TL, Thomas KK et al. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 2007; 45: 3270.
  10. Swidsinski A, Mendling W, Loening-Baucke V et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005; 106: 1013.
  11. Yen S, Shafer MA, Moncada J et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol 2003; 102: 927.
  12. Fethers KA, Fairley CK, Morton A et al. Early sexual experiences and risk factors for bacterial vaginosis. J Infect Dis 2009; 200: 1662.
  13. Joesoef, M, Schmid G. Bacterial vaginosis. In: Clinical evidence. BMJ Publishing Group, London 2001; 4: 887.
  14. Morris M, Nicoll A, Simms I et al. Bacterial vaginosis: a public health review. BJOG 2001; 108: 439.
  15. Ness RB, Kip KE, Soper DE et al. Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Transm Dis 2006; 33: 381.
  16. Ness RB, Hillier SL, Richter HE et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002; 100: 765.
  17. Schwebke JR, Desmond RA, Oh MK. Predictors of bacterial vaginosis in adolescent women who douche. Sex Transm Dis 2004; 31: 433.
  18. Brotman RM, Klebanoff MA, Nansel TR et al. A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol 2008; 168: 188.
  19. Klebanoff MA, Nansel TR, Brotman RM et al. Personal hygienic behaviors and bacterial vaginosis. Sex Transm Dis 2010; 37: 94.
  20. Amsel R, Totten PA, Spiegel CA et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14.
  21. Klebanoff MA, Schwebke JR, Zhang J et al. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 2004; 104: 267.
  22. Marrazzo JM, Wiesenfeld HC, Murray PJ et al. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 2006; 193: 617.
  23. Кисина В.И., Полищук Н.А., Говорун В.М. Дифференциальные подходы к ведению пациенток с различными видами течения бактериального вагиноза. Вестн. дерматол. венерол. 2002; 5: 15-20.
  24. Тихомиров А.Л., Олейник Ч.Г. Бактериальный вагиноз. Оптимизация лечения бактериального вагиноза. Cons. Med. 2005; 1 (7).
  25. Bump RC, Buesching WJ. Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Ginecol 1988; 157: 935-9.
  26. Cook RL, Redono-Lopez V, Schmitt C et al. Clinical, microbiological and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 1992; 30: 870-7.
  27. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Inf 2004; 80 (1): 8-11.
  28. Европейское руководство по заболеваниям, передаваемым половым путем. М., 2004.
  29. Методические материалы по диагностике и лечению наиболее распространенных инфекций, передаваемых половым путем и заболеваний кожи. Под ред. А.А.Кубановой. М.: ГЭОТАР-МЕД, 2003.
  30. Ransom SB, McComish JF, Greenberg R, Tolford DA. Oral metronidasole vs. Metrogel Vaginal for treating bacterial vaginosis. Cost-effectiveness evaluation. J Reprod Med 1999; 44 (4): 359-62.
  31. Yudin MH, Landers DV, Meyn L, Hillier SL. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy. Obstet Gynecol 2003; 102 (3): 527-34.
  32. Базисная и клиническая фармакология. Под ред. Б.Г.Катцунга. Пер. с англ. Э.Э.Звартау. В 2 т. М.-СПб.: Бином, Невский диалект, 1998.
  33. Boeke aJ et al. Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomized clinical trial. Genitourin Med 1993; 69 (5): 388-92.
  34. Goldsteain EJ, Citron DM, Merriam CV et al. In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Garnerella vaginalis. Antimicrob Agents Chemother 2002; 46: 3995.
  35. Beigi RH, Austin MN, Meyn LA et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004; 191: 1123-9.
  36. Paavonen J, Mangioni C, Martin MA, Wajszczuk CP. Vaginal clindamycin and oral metronidasole for bacterial vaginosis: a randomized trial. Obstet Gynecol 2000; 96 (2): 256-60.
  37. Petersen EE. Der Einsatz von Vitamin C (Vagi-C) zur Normalisierung der Vaginalflora. Gyne 1998; 19.
  38. Polatti F, Rampino M, Magnani P, Mascarucci P. Vaginal pH lowering effect of a vaginal tablet, containing 250 mg of Vitamin C, in subjects with high vaginal pH.
  39. Уварова Е.В., Султанова Ф.Ш. Влагалище как микроэкосистема в норме и при воспалительных процессах гениталий различной этиологии. Гинекология. 2002; 4 (4).
  40. Громова О.А., Торшин И.Ю., Гарасько Е.А. Молекулярные механизмы топического назначения витамина С в лечении бактериального вагиноза. Акуш. и гинекол. 2010; 11: 37-42.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-63961 от 18.12.2015.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies